<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[MP Biomedicals, LLC 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=23931></link><description><![CDATA[MP Biomedicals, LLC 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 16:00:46 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2014/12/3554153577_20141212150824_1994312559.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[MP Biomedicals Receives First Ever FDA Approval for HTLV Confirmatory Assay]]></title><link>https://www.newswire.co.kr/newsRead.php?no=777110</link><description><![CDATA[SANTA ANA, Calif.--(Business Wire/Korea Newswire)--MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products, announced today that it has received FDA approval on the MP Diagnostics HTLV (Human T-Cell Lymphotropic Virus) Blot 2.4, a Western Blot for HTLV confirmatory testing and viral type discrimination. This approval signifies the first ever FDA a...]]></description><pubDate>Fri, 12 Dec 2014 15:20:00 +0900</pubDate></item><item><title><![CDATA[MP 바이오메디칼, HTLV 확정검사에 대해 최초로 FDA 승인 획득]]></title><link>https://www.newswire.co.kr/newsRead.php?no=777111</link><description><![CDATA[산타아나, 캘리포니아--(Business Wire/뉴스와이어)--생명과학 시약, 정밀화학 및 진단 제품을 제공하는 유수 업체인 MP 바이오메디칼(MP Biomedicals, LLC)은 오늘 FDA(미국 식품의약청)로부터 HTLV 확정검사 및 바이러스 타입 식별을 위한 웨스턴 블롯(Western Blot)인 MP 다이그노스틱스 HTLV(인체 T-림프영양성 바이러스, Human T-Cell Lymphotropic Virus) 블롯 2.4(MP Diagnostics HTLV Blot 2.4)에 대한 승인을 취득했다...]]></description><pubDate>Fri, 12 Dec 2014 15:20:00 +0900</pubDate></item></channel></rss>